Modine Manufacturing Company vs Regeneron Pharmaceuticals Inc — how do they compare? Modine Manufacturing Company trades at $248 (market cap $12.18B), while Regeneron Pharmaceuticals Inc trades at $670 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 5.8× Modine Manufacturing Company's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals.
| MOD | REGN | |
|---|---|---|
Market Cap | $12.18B | $70.47B |
Sector | Technology | Health |
52-Week High | $306.89 | $812.27 |
52-Week Low | $93.71 | $545.46 |
Enterprise Value | $12.54B | $64.42B |
Dividend Yield | — | 0.56% |
Trailing returns across standard periods
Latest headlines on both assets
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →